chikungunya - dofaq.co
Epidemiological Update - Chikungunya in the Region of the Americas - 22 April 2024
Pan American Health Organization - 22 Apr 2024
Epidemiological Update - Chikungunya in the Region of the Americas - 22 April 2024 ...
Countries/territories reporting Chikungunya cases since February 2023 and as of January 2024
European Union - 16 Feb 2024
Countries/territories reporting Chikungunya cases since February 2023 and as of January 2024 ...
Chikungunya vaccine: US approves first shot against mosquito-borne virus
BBC.com - 09 Nov 2023
Chikungunya vaccine: US approves first shot against mosquito-borne virus ...
Chikungunya information for travelers
World Health Organization (WHO) - 23 Nov 2023
Chikungunya information for travelers ...
Enhanced attenuation of chikungunya vaccines expressing antiviral cytokines | npj Vaccines
Nature.com - 12 Mar 2024
Enhanced attenuation of chikungunya vaccines expressing antiviral cytokines | npj Vaccines ...
Chikungunya in Timor-Leste - Level 2 - Level 2 - Practice Enhanced Precautions - Travel Health Notices | Travelers ...
CDC - 08 Feb 2024
Chikungunya in Timor-Leste - Level 2 - Level 2 - Practice Enhanced Precautions - Travel Health Notices | Travelers ... ...
Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine
Valneva - 10 Jan 2024
Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine ...
Vaccine Against Chikungunya Approved By The FDA. Should You Get It?
Forbes - 20 Nov 2023
Vaccine Against Chikungunya Approved By The FDA. Should You Get It? ...
Chikungunya Virus: Background, Pathophysiology, Etiology
Medscape Reference - 29 Nov 2023
Chikungunya Virus: Background, Pathophysiology, Etiology ...
Understanding how chikungunya virus affects the brain and body
News-Medical.Net - 12 Mar 2024
Understanding how chikungunya virus affects the brain and body ...
FDA approves a live, attenuated chikungunya vaccine using accelerated approval
IDSA - 13 Nov 2023
FDA approves a live, attenuated chikungunya vaccine using accelerated approval ...
The Americas seek to expand genomic surveillance for dengue, chikungunya and other mosquito-borne viruses
Pan American Health Organization - 16 Aug 2023
The Americas seek to expand genomic surveillance for dengue, chikungunya and other mosquito-borne viruses ...
Chikungunya virus cell-to-cell transmission is mediated by intercellular extensions in vitro and in vivo
Nature.com - 17 Aug 2023
Chikungunya virus cell-to-cell transmission is mediated by intercellular extensions in vitro and in vivo ...
U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva's Single-Dose Chikungunya Vaccine IXCHIQ®
Valneva - 29 Feb 2024
U.S. CDC Advisory Committee (ACIP) Recommends Use of Valneva's Single-Dose Chikungunya Vaccine IXCHIQ® ...
12-month Chikungunya virus disease case notification rate per 100 000 population, July 2022–June 2023
European Union - 31 Jul 2023
12-month Chikungunya virus disease case notification rate per 100 000 population, July 2022–June 2023 ...
Zika, chikungunya and co-occurrence in Brazil: space-time clusters and associated environmental–socioeconomic ...
Nature.com - 21 Oct 2023
Zika, chikungunya and co-occurrence in Brazil: space-time clusters and associated environmental–socioeconomic ... ...
EMA Accepts Valneva's Chikungunya Vaccine Marketing Authorization Application for Accelerated Assessment
Valneva - 27 Nov 2023
EMA Accepts Valneva's Chikungunya Vaccine Marketing Authorization Application for Accelerated Assessment ...
Statistical modeling for identifying chikungunya high-risk areas of two large-scale outbreaks in Thailand's southernmost ...
Nature.com - 03 Nov 2023
Statistical modeling for identifying chikungunya high-risk areas of two large-scale outbreaks in Thailand's southernmost ... ...
Valneva Reports Positive Pivotal Phase 3 Immunogenicity Data in Adolescents for its Single-Shot Chikungunya ...
Valneva - 13 Nov 2023
Valneva Reports Positive Pivotal Phase 3 Immunogenicity Data in Adolescents for its Single-Shot Chikungunya ... ...